Breaking News

Fujifilm Diosynth Biotechnologies Celebrates the Start of Its Expansion Project in Texas

The expansion will add a new cGMP production facility that will be operational by 2024.

Author Image

By: Charlie Sternberg

Associate Editor

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization for biologics, vaccines, and advanced therapies, held a groundbreaking ceremony on October 25 to celebrate the start of its single-use manufacturing campus expansion project in College Station, Texas.   The expansion will add a new cGMP production facility that will be operational by 2024, and is expected to add 150 skilled positions to the site. The expansion will double the Company’s advanced therapy and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters